MediMer: a Versatile Do-It-yourself Peptide-Receptive MHC Class I Multimer Platform for Tumor Neoantigen-Specific T Cell Detection
FRONTIERS IN IMMUNOLOGY(2024)
Key words
T cells,tumor immunotherapy,peptide-MHC class I multimer,neoepitope screening,T cell receptor discovery,tumor neoantigen,personalized medicine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined